Abstract
Autoimmune diseases result from disrupted tolerance to self-antigens and subsequent damage to tissues and organs. In several diseases, specific autoantibodies have been either proved or suspected to play a role in this process. Consequently, several strategies have been devised in an attempt to discard the destructive immunoglobulins. Currently, both nonselective and epitope-specific methods are applied in several diseases. In this review, we provide a summary of the available data on elimination of pathogenic autoantibodies and discuss the advantages and pitfalls of the different approaches.
Original language | English |
---|---|
Pages (from-to) | 635-646 |
Number of pages | 12 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1051 |
DOIs | |
State | Published - 2005 |
Externally published | Yes |
Keywords
- Apheresis
- Autoantibodies
- Dilated cardiomyopathy
- Immunoadsorption
- Myasthenia gravis
- Systemic lupus erythematosus